Thanks Martin and good morning, everyone. I will now provide you with some additional details on the second quarter 2024 financial results. I will then provide an update on our outlook for the full year. For the second quarter 2024, net sales increased $4 million or a 3% year-over-year to $144 million, driven by Vita Coco Coconut Water net sales growth of 4% and Private Label declines of 4%. On a segment basis within the Americas, Vita Coco Coconut Water increased net sales by 4% to $98 million while Private Label decreased 4% to $23 million as we saw the impacts of the transition out of the Private Label Coconut Oil relationship that we had previously indicated would happen. Vita Coco Coconut Water saw a 1% volume increase and a 3% net price mix benefit. While private label increased 11% in volume, this was offset by price mix changes due to the coconut oil transition leading to a net sales decline of 4%. Our Americas Vita Coco Coconut Water scan trends remain very healthy. Our shipment results in the quarter allowing the scan trends primarily reflecting the challenges in obtaining ocean freight containers that Martin outlined earlier. For the second quarter 2024, our International segment net sales were up 7% with Vita Coco Coconut Water growth of 10% where strong growth in Europe was partially offset by volume softness in Asia. Private Label revenue declined 5% where strong Private Label Coconut Water net sales was more than offset by the transition out of the Private Label Coconut Oil relationship we referenced earlier. On a quarterly basis, consolidated growth profit was $59 million, up $8 million versus the prior year period. On a percentage basis, gross margins were very strong at 41% on the quarter. An improvement of approximately 400 basis points over the 37% reported in Q2 2023. These increases resulted from decreased finished goods and domestic transportation costs, branded pricing, and mixed effects within private label products. Moving on to operating expenses, second quarter 2024 SG&A costs decreased 5% to $29 million. The reduction was driven by the timing of marketing investments, partially offset by higher year-on-year personnel expenses. Net income attributable to shareholder for the second quarter of 2024 was $19 million or $0.32 per diluted share, compared to $18 million or $0.31 per diluted share for the prior year. Net income for the quarter benefited primarily from increased gross profit and decreased SG&A cost, partially offset by a higher year-on-year impact from unrealized FX derivatives and higher year-on-year tax expense. Our effective tax rate for the second quarter, 2024, was 25%, versus 19% in the prior year quarter. This represents a year-to-date ETR of 23%, versus 20% last year. The increase was driven by a jurisdictional mix of the pretax profits and impact of higher non-deductible expense this year related to covered employees' compensation compared to last year. Second quarter 2024, adjusted EBITDA, our non-GAAP measure which is defined and reconciled in our pressure release was $32 million, or 22.4% of net sales, up from $24 million, or 17.2% of net sales in 2023. The increase was primarily due to the gross profit improvements previously discussed. Turning to our balance sheet and cash flow, as of June 30, 2024, we had total cash on hand of $150 million and no debt under our revolving credit facility, compared to $133 million of cash, and no debt as of December 31, 2023. The increase in the cash position was due to strong net income partially offset by increase of working capital of $22 million, and the year-to-date repurchase of shares valued at $10 million. Working capital was driven by a $29 million increase in accounts receivable, which is due to the timing of customer payments. Inventory decreased $5 million due to the inventory delays Martin discussed earlier. Based on our year-to-date performance, our confidence in the health of the category and our Vita Coco brand, we are reaffirming our full year guidance. We expect net sales between $500 million and $510 million, with expected gross margins for the full year of 37% to 39%, delivering adjusted EBITDA of $76 million to $82 million. The guidance reflects our current best assumptions on marketplace trends and our global supply chain costs. It assumes a flow of product to our market to the same rate as we are experiencing July. While we are confident in the underlying strength of our business, we are maintaining the range on net sales and EBITDA guidance to reflect continued uncertainty on the transportation cost side. For the balance of year, we plan to adjust promotional activity to reflect expected product availability which will allow us to deliver our gross margin adjusted EBITDA guidance while absorbing the higher global transportation costs we are currently seeing, which we estimate in the second half of the year to be approximately $15 million of increased transportation costs in a rate-pe -case equivalent basis over the equivalent first-half rate-per-case equivalent. As Martin mentioned, these higher costs were delayed in reaching our P&L to the container shipping delays and are now expected to impact our P&L in Q3, with more significant impact in Q4 due to current rates. We expect disciplined SG&A spending with full year 2024 SG&A flat to slightly increasing year-on-year. We may adjust our SG&A spending if we see improvements in ocean freight quicker than expected or if we see productive investment opportunities to strengthen the business for the long term. We anticipate our cash balance will remain healthy through the year, allowing us to fund any potential M&A opportunities that emerge. Support for the share buyback activity and continue to invest in our business for long-term growth. And with that, I'd like to turn the call back to Martin for his closing remarks.